ACER THERAPEUTICS INC. Proceeds from Convertible Debt
ACER THERAPEUTICS INC. reported Proceeds from Convertible Debt of $5.52 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2023-11-20
- ACER THERAPEUTICS INC. proceeds from convertible debt for the quarter ending 2022-12-31 was $0.00.
- ACER THERAPEUTICS INC. proceeds from convertible debt for the quarter ending 2022-09-30 was $0.00.
- ACER THERAPEUTICS INC. proceeds from convertible debt for the quarter ending 2022-06-30 was $0.00.
- ACER THERAPEUTICS INC. proceeds from convertible debt for the quarter ending 2022-03-31 was $5.52M.
- ACER THERAPEUTICS INC. proceeds from convertible debt for fiscal 2022 was $5.52M.
- ACER THERAPEUTICS INC. proceeds from convertible debt for fiscal 2012 was $3.46M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 116 month | Proceeds from Convertible Debt 119 month | Proceeds from Convertible Debt 122 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $0.00 derived: sum of 3 quarters · filed 2023-11-20 | $5.52M 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $5.52M 10-Q · filed 2023-11-20 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.52M 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | $5.52M 10-Q · filed 2023-05-15 | ||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $550.00K 10-Q · filed 2014-08-14 | $550.00K derived: sum of 3 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $550.00K 10-Q · filed 2013-05-14 | $550.00K derived: sum of 2 quarters · filed 2013-05-14 | $13.29M 10-Q · filed 2013-05-14 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $3.46M 10-K · filed 2013-03-29 | $12.74M 10-K · filed 2013-03-29 | ||||
| 2012-09-30 | $3.46M 10-Q · filed 2012-11-14 | $12.74M 10-Q · filed 2012-11-14 |